Wonder Club world wonders pyramid logo
×

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America Book

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America
Be the First to Review this Item at Wonderclub
X
Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America, Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; , Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America
out of 5 stars based on 0 reviews
5
0 %
4
0 %
3
0 %
2
0 %
1
0 %
Digital Copy
PDF format
1 available   for $99.99
Original Magazine
Physical Format

Sold Out

  • Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America
  • Written by author Ross Levine
  • Published by Elsevier Health Sciences, 11/11/2012
  • Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs;
Buy Digital  USD$99.99

WonderClub View Cart Button

WonderClub Add to Inventory Button
WonderClub Add to Wishlist Button
WonderClub Add to Collection Button

Book Categories

Authors

Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.


Login

  |  

Complaints

  |  

Blog

  |  

Games

  |  

Digital Media

  |  

Souls

  |  

Obituary

  |  

Contact Us

  |  

FAQ

CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!!

X
WonderClub Home

This item is in your Wish List

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America, Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; , Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

X
WonderClub Home

This item is in your Collection

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America, Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; , Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

X
WonderClub Home

This Item is in Your Inventory

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America, Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; , Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

WonderClub Home

You must be logged in to review the products

E-mail address:

Password: